Name

7+3

Alternate names

None

Primary Site

None

Histology

None

Radiation

None

Remarks

None

Drugs for 7+3

Name

Alternate Names

CL 232315
Mitoxantrone Hydrochloride
Mitozantrone
Novantrone

Abbreviations

DAD
DHAD
DHAQ

Category

Chemotherapy

Subcategory

Antitumor antibiotic

NSC Number

301739

Primary Site

Acute myelogenous leukemia (AML)
Non-Hodgkin lymphoma

Histology

None

Remarks

Antibiotic-class antineoplastic. FDA approved uses in adult acute non-lymphocytic leukemia, and prostate cancer pain reduction in combination with prednisone. Novantrone is a synthetic antineoplastic anthracenedione

Coding

This drug should be coded

Name

Alternate Names

Acetyladriamycin
Cerubidine
Dauno-blastin
Daunomycin
Daunomycin-HCl
Daunorubicin
Daunorubicine
FI-6339
Leuk-aemomycin C
NDC-0082-4155
RP-13057
Rubidomycin
Rubidomycin HCl
Rubomycin C

Abbreviations

Daun
Dauno
DNM
DNR
DRB

Category

Chemotherapy

Subcategory

NSC Number

082151
82151

Primary Site

Histology

None

Remarks

FDA approved use on ALL and ANLL; antitumor antibiotic

Coding

This drug should be coded

Name

Alternate Names

4-Demethoxydaunorubicin
Idamycin
Idamycin PFS
Idarubicin hydrochloride
IMI 30
IMI-30
SC-33428

Abbreviations

4-DMDR
IDA

Category

Chemotherapy

Subcategory

Antitumor antibiotic

NSC Number

256439

Primary Site

Acute lymphoblastic leukemia (ALL)
Acute myelogenous leukemia (AML)
Chronic myelogenous leukemia in blast crises
Myelodysplastic syndromes (MDS)

Histology

None

Remarks

An anthracycline antineoplastic agent. FDA approved uses on acute lymphocytic and non-lymphcytic leukemia.

Coding

This drug should be coded

Name

Alternate Names

AC-1075
Alexan
Ara-cytidine
Arabinocytidine
Arabinosylcytosine
Beta-Arabinosylcytosine
Cytarabin
Cytarabine
Cytarabinoside
Cytosar
Cytosar-U
Cytosine Arabinoside
Cytosine arabinoside hydrochloride
Spongocytidine HCL
Tarabine
Tarabine PFS
U-19920
U-19920A
WR-28453

Abbreviations

ara-C
CA
HDA
HDARA-C

Category

Chemotherapy

Subcategory

NSC Number

063878
63878

Primary Site

ALL
AML
CML
Hodgkin's disease
NHL

Histology

None

Remarks

Antineoplastic agent; antimetabolite. FDA approved uses on Hodgkin's disease, leukemia; under investigation for Rx of Progressive Multifocal Leukoencephalopathy (PML)

Coding

This drug should be coded
Glossary